Breaking News
Close
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
59.83 +0.74    +1.25%
07:11:00 - Delayed Data. Currency in EUR ( Disclaimer )
  • Volume: 100
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 59.83 - 59.85
Type:  Equity
Market:  Germany
ISIN:  US3755581036 
S/N:  885823
Gilead 59.83 +0.74 +1.25%
  • General    
  • Chart    
  • News & Analysis    
  • Financials    
  • Technical    
  • Forum    
  • InvestingPro
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Customise

Candlestick Patterns

Time Frame
Pattern Indication
Type
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Downside Gap Three Methods 1W Current
Hanging Man 1D Current
Hanging Man 5H Current
Completed Patterns
Three Black Crows 1W 2 Jun 12, 2022
Belt Hold Bearish 1H 2 Jun 24, 2022 07:00
Belt Hold Bearish 30 2 Jun 24, 2022 07:00
Belt Hold Bearish 15 2 Jun 24, 2022 07:00
Harami Cross 1M 3 Mar 22
Harami Bearish 1D 3 Jun 22, 2022
Doji Star Bearish 5H 4 Jun 23, 2022 12:00
Tri-Star Bearish 30 4 Jun 23, 2022 16:30
Tri-Star Bearish 15 4 Jun 23, 2022 16:45
Upside Gap Three Methods 1M 5 Jan 22
Hanging Man 1W 5 May 22, 2022
Three Outside Up 1M 6 Dec 21
Deliberation Bearish 1W 6 May 15, 2022
Doji Star Bearish 1W 6 May 15, 2022
Belt Hold Bearish 1H 6 Jun 23, 2022 13:00
Harami Bullish 30 6 Jun 23, 2022 13:30
Harami Cross 30 6 Jun 23, 2022 13:30
Bullish Engulfing 1M 7 Nov 21
Abandoned Baby Bearish 5H 7 Jun 22, 2022 06:00
Evening Doji Star 5H 7 Jun 22, 2022 06:00
Evening Star 5H 7 Jun 22, 2022 06:00
Belt Hold Bearish 30 7 Jun 23, 2022 13:00
Tri-Star Bearish 15 7 Jun 23, 2022 13:15
Doji Star Bearish 5H 8 Jun 21, 2022 15:00
Doji Star Bearish 1M 9 Sep 21
Harami Cross Bearish 5H 10 Jun 21, 2022 05:00
Tri-Star Bearish 1H 11 Jun 22, 2022 07:00
Tri-Star Bearish 15 13 Jun 22, 2022 07:00
Inverted Hammer 1W 14 Mar 20, 2022
Engulfing Bearish 1W 16 Mar 06, 2022
Tri-Star Bullish 15 16 Jun 21, 2022 13:45
Tri-Star Bearish 30 17 Jun 21, 2022 07:00
Tri-Star Bullish 5H 18 Jun 16, 2022 05:00
Inverted Hammer 1M 19 Nov 20
Bullish doji Star 1W 19 Feb 13, 2022
Tri-Star Bearish 15 19 Jun 21, 2022 07:00
Tri-Star Bearish 1H 20 Jun 20, 2022 10:00
Harami Bullish 1W 22 Jan 23, 2022
Harami Cross 1W 22 Jan 23, 2022
Hanging Man 1D 25 May 23, 2022
Tri-Star Bearish 15 25 Jun 20, 2022 10:45
Harami Cross 1D 26 May 20, 2022
Belt Hold Bullish 5H 26 Jun 10, 2022 14:00
Harami Cross Bearish 1W 27 Dec 19, 2021
Tri-Star Bullish 1H 28 Jun 16, 2022 07:00
Harami Cross Bearish 1W 30 Nov 28, 2021
Harami Bearish 1W 30 Nov 28, 2021
Harami Bullish 1D 30 May 16, 2022
Tri-Star Bullish 30 31 Jun 16, 2022 07:00
Tri-Star Bullish 15 32 Jun 16, 2022 16:00
Tri-Star Bullish 15 34 Jun 16, 2022 07:00
Tri-Star Bullish 1H 36 Jun 13, 2022 13:00
Harami Cross 1W 38 Oct 03, 2021
Harami Bullish 1M 39 Mar 19
Falling Three Methods 1D 42 Apr 28, 2022
Tri-Star Bullish 15 43 Jun 13, 2022 13:15
Engulfing Bearish 1M 44 Oct 18
Tri-Star Bullish 1H 44 Jun 09, 2022 13:00
Harami Bullish 5H 45 May 30, 2022 13:00
Harami Cross 5H 45 May 30, 2022 13:00
Tri-Star Bearish 15 45 Jun 13, 2022 07:00
Tri-Star Bullish 15 46 Jun 10, 2022 18:30
Tri-Star Bullish 5H 48 May 27, 2022 10:00
Tri-Star Bullish 30 48 Jun 09, 2022 13:00
Tri-Star Bullish 15 48 Jun 10, 2022 07:15
Dragonfly Doji 1M 49 May 18
Tri-Star Bearish 30 49 Jun 09, 2022 07:00
Falling Three Methods 1M 51 Mar 18
Bullish doji Star 1H 51 Jun 07, 2022 15:00
Three Inside Up 1W 52 Jun 27, 2021
Tri-Star Bullish 15 52 Jun 09, 2022 13:15
Harami Bullish 1W 53 Jun 20, 2021
Harami Cross 1W 53 Jun 20, 2021
Tri-Star Bullish 30 53 Jun 08, 2022 07:00
Tri-Star Bearish 15 53 Jun 09, 2022 07:00
Inverted Hammer 5H 54 May 24, 2022 12:00
Tri-Star Bullish 1H 54 Jun 07, 2022 12:00
Three Black Crows 1M 55 Nov 17
Three Outside Up 1W 55 Jun 06, 2021
Tri-Star Bearish 1H 56 Jun 06, 2022 07:00
Tri-Star Bullish 15 57 Jun 08, 2022 07:00
Tri-Star Bullish 30 59 Jun 07, 2022 12:00
Engulfing Bearish 1D 61 Mar 30, 2022
Tri-Star Bearish 30 61 Jun 06, 2022 07:00
Harami Cross 1W 63 Apr 11, 2021
Tri-Star Bullish 15 63 Jun 07, 2022 12:00
Tri-Star Bullish 30 65 Jun 03, 2022 11:00
Tri-Star Bearish 15 65 Jun 06, 2022 07:00
Doji Star Bearish 1D 67 Mar 22, 2022
Tri-Star Bullish 1H 67 Jun 01, 2022 07:00
Tri-Star Bearish 30 68 Jun 02, 2022 14:30
Three Outside Up 1D 69 Mar 18, 2022
Tri-Star Bullish 15 69 Jun 03, 2022 11:00
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Comments

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai Apr 27, 2021 7:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job GILD. bullish move forward
Ashraf Elgendy
Ashraf Elgendy Mar 07, 2021 13:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...
RM RM
RM RM Mar 01, 2021 21:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Up Again
Ken Laing
Ken Laing Oct 23, 2020 18:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to load up before the big rise coming next week
Iggy Maldon
Iggy Maldon Jul 30, 2020 20:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Classic pump n’ dump. What a shambles
RM RM
RM RM May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will reach above 95
Chili Daug
Chili Daug May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when? hahah
SAGAR AGARWAL
SAGAR AGARWAL May 15, 2020 14:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good time to accumulate.
Khizer Malik
Khizer Malik May 14, 2020 11:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr
Willy Chin
Willy Chin Apr 23, 2020 18:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
High chance to be trading above 90, good long stock
Viktor Veselý
Viktor Veselý Apr 12, 2020 7:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Our Apps
DOWNLOAD APPApp store
Investing.com
© 2007-2022 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
  • Sign up for FREE and get:
  • Real-Time Alerts
  • Advanced Portfolio Features
  • Personalized Charts
  • Fully-Synced App
Continue with Google
or
Sign up with Email